Xianghua Fu Selected Research

Xianghua Fu Research Topics

Disease

12	Myocardial Infarction 11/2020 - 09/2009
11	ST Elevation Myocardial Infarction 01/2021 - 01/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2014
5	Heart Failure 04/2016 - 07/2010
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2021 - 02/2019
2	Inflammation (Inflammations) 01/2021 - 12/2015
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 08/2020
2	Diabetes Mellitus 08/2020 - 02/2019
2	Hypertension (High Blood Pressure) 08/2020 - 02/2019
2	Chest Pain (Chest Pains) 01/2019 - 11/2015
2	Acute Coronary Syndrome 01/2017 - 08/2013
2	Renal Insufficiency (Renal Failure) 04/2016 - 07/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 12/2015 - 03/2015
1	Left Ventricular Dysfunction 08/2021
1	Ventricular Remodeling 08/2021
1	Anterior Wall Myocardial Infarction 08/2021
1	Chronic Renal Insufficiency 02/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Insulin Resistance 01/2021
1	Atrial Fibrillation 12/2020
1	Fibrosis (Cirrhosis) 12/2020
1	Pulmonary Hypertension 10/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 08/2020
1	Hyperuricemia 08/2020
1	Atrial Heart Septal Defects (Atrial Septal Defect) 01/2020
1	Shock 12/2015
1	Unstable Angina 12/2015
1	Poisoning 12/2015
1	Infarction (Infarctions) 11/2015
1	Thrombosis (Thrombus) 09/2015
1	Inferior Wall Myocardial Infarction 09/2015
1	Cardiac Arrhythmias (Arrythmia) 12/2014
1	Hemorrhage 08/2013
1	Ischemia 05/2013
1	Atherosclerosis 09/2009

Drug/Important Bio-Agent (IBA)

5	omega-Chloroacetophenone (Mace)IBA 01/2017 - 01/2014
5	anisodamineIBA 06/2016 - 01/2011
4	C-Reactive ProteinIBA 01/2021 - 12/2015
4	Troponin IIBA 01/2021 - 02/2019
4	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2016 - 07/2010
3	oxidized low density lipoproteinIBA 01/2021 - 02/2019
2	Uric Acid (Urate)IBA 01/2021 - 02/2019
2	Natriuretic PeptidesIBA 01/2021 - 02/2019
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 08/2020
2	CholesterolIBA 08/2020 - 09/2009
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 10/2014
2	N(2)-(3-trifluoromethylphenyl)guanineIBA 01/2020 - 09/2015
2	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2016 - 11/2015
1	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021
1	CreatinineIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	Long Noncoding RNAIBA 12/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2020
1	ferulic acid (sodium ferulate)IBA 10/2020
1	LDL CholesterolIBA 08/2020
1	Sirolimus (Rapamycin)FDA Link 08/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020
1	IsoenzymesIBA 01/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2017
1	Saline SolutionIBA 06/2016
1	Phosphorus (Red Phosphorus)IBA 12/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015
1	Alprostadil (Muse)FDA LinkGeneric 12/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2015
1	AlkaloidsIBA 12/2015
1	MB 3 (MB-3)IBA 11/2015
1	Nicorandil (SG 75)IBA 09/2015
1	alkylate 215 (A 215)IBA 03/2015
1	Diltiazem (Cardizem)FDA LinkGeneric 12/2014
1	Tirofiban (Aggrastat)FDA Link 08/2013
1	reteplase FDA Link 05/2013
1	PotassiumIBA 09/2012
1	Atorvastatin (Lipitor)FDA Link 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2009
1	Simvastatin (Zocor)FDA LinkGeneric 09/2009

Therapy/Procedure

20	Percutaneous Coronary Intervention 02/2021 - 07/2010
4	Stents 01/2021 - 03/2015
4	Length of Stay 09/2015 - 07/2010
3	Drug-Eluting Stents 02/2021 - 02/2019
2	Intravenous Infusions 11/2015 - 01/2011
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2021
1	Septal Occluder Device 01/2020
1	Intravenous Administration 12/2015
1	Intravenous Injections 11/2015
1	Patient Readmission 03/2015
1	Injections 12/2014
1	Ischemic Postconditioning 10/2014
1	Punctures 01/2014
1	Therapeutics 09/2009